Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 12, 2012, Pages

  Goriounova, Natalia A ^a   Mansvelder, Huibert D ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIBATIDINE; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINE; NICOTINIC RECEPTOR; GANGLION STIMULATING AGENT;

ARTICLE; BRAIN DEVELOPMENT; CHOLINERGIC STIMULATION; COGNITIVE DEFECT; DOWN REGULATION; DRUG ACTIVITY; DRUG EXPOSURE; ELECTROPHYSIOLOGY; GABAERGIC TRANSMISSION; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; LONG TERM EXPOSURE; LONG TERM POTENTIATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRESYNAPTIC INHIBITION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; THALAMOCORTICAL TRACT; UPREGULATION; WORKING MEMORY; ADOLESCENT; ANIMAL; BRAIN DISEASE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EXECUTIVE FUNCTION; NERVE CELL; PATHOPHYSIOLOGY; RAT; REVIEW; SMOKING; SYNAPSE;

RODENTIA;

ADOLESCENT; ANIMALS; BRAIN DISEASES; COGNITION DISORDERS; EXECUTIVE FUNCTION; GANGLIONIC STIMULANTS; HUMANS; NERVE NET; NEURONS; NICOTINE; PREFRONTAL CORTEX; RATS; SMOKING; SYNAPSES; UP-REGULATION;

EID: 84870764687     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a012120     Document Type: Article

References (130)

1. Abreu-Villaca Y, Seidler FJ, Qiao D, Tate CA, Cousins MM, Thillai I, Slotkin TA. 2003. Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: Critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology 28: 1935-1949.
2. Adriani W, Spijker S, Deroche-Gamonet V, Laviola G, Le Moal M, Smit AB, Piazza PV. 2003. Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 23: 4712-4716.
3. Alkondon M, Albuquerque EX. 2004. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res 145: 109-120.
4. Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX. 2000. Nicotinic receptor activation in human cerebral cortical interneurons: A mechanism for inhibition and disinhibition of neuronal networks. J Neurosci 20: 66-75.
5. Arnett JJ. 2000. Optimistic bias in adolescent and adult smokers and nonsmokers. Addict Behav 25: 625-632.
6. Belluzzi JD, Lee AG, Oliff HS, Leslie FM. 2004. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) 174: 389-395.
7. Bergstrom HC, McDonald CG, French HT, Smith RF. 2008. Continuous nicotine administration produces selective, age-dependent structural alteration of pyramidal neurons from prelimbic cortex. Synapse 62: 31-39.
8. Bradley SR, Marino MJ, Wittmann M, Rouse ST, Awad H, Levey AI, Conn PJ. 2000. Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata. J Neurosci 20: 3085-3094.
9. Brielmaier JM, McDonald CG, Smith RF. 2007. Immediate and long-term behavioral effects of a single nicotine injection in adolescent and adult rats. Neurotoxicol Teratol 29: 74-80.
10. Brook JS, Cohen P, Brook DW. 1998. Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry 37: 322-330.
11. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M. 2002. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Arch Gen Psychiatry 59: 1039-1044.
12. Brook JS, Schuster E, Zhang C. 2004. Cigarette smoking and depressive symptoms: A longitudinal study of adolescents and young adults. Psychol Rep 95: 159-166.
13. Brown RW, Kolb B. 2001. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res 899: 94-100.
14. Brown RA, Lewinsohn PM, Seeley JR, Wagner EF. 1996. Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J Am Acad Child Psychiatry 35: 1602-1610.
15. Brunzell DH, Russell DS, Picciotto MR. 2003. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J Neurochem 84: 1431-1441.
16. Casey BJ, Tottenham N, Liston C, Durston S. 2005. Imaging the developing brain: What have we learned about cognitive development? Trends Cogn Sci 9: 104-110.
17. Cervilla JA, Prince M, Mann A. 2000. Smoking, drinking, and incident cognitive impairment: A cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry 68: 622-626.
18. Chambers RA, Taylor JR, Potenza MN. 2003. Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. Am J Psychiatry 160: 1041-1052.
19. Choi WS, Patten CA, Gillin JC, Kaplan RM, Pierce JP. 1997. Cigarette smoking predicts development of depressive symptoms among U. S. adolescents. Ann Behav Med 19: 42-50.
20. Chung S, Li X, Nelson SB. 2002. Short-term depression at thalamocortical synapses contributes to rapid adaptation of cortical sensory responses in vivo. Neuron 34: 437-446.
21. Colby SM, Tiffany ST, Shiffman S, Niaura RS. 2000. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend 59: S83-S95.
22. Conn PJ, Lindsley CW, Jones CK. 2009. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol Sci 30: 25-31.
23. Couey JJ, Meredith RM, Spijker S, Poorthuis R, Smit AB, Brussaard AB, Mansvelder HD. 2007. Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex. Neuron 54: 73-87.
24. Counotte DS, Spijker S, Van de Burgwal LH, Hogenboom F, Schoffelmeer AN, De Vries TJ, Smit AB, Pattij T. 2009. Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology 34: 299-306.
25. Counotte DS, Goriounova NA, Li KW, Loos M, van der Schors RC, Schetters D, Schoffelmeer ANM, Smit AB, Mansvelder HD, Pattij T, et al. 2011. Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence. Nat Neurosci 14: 417-419.
26. Counotte DS, Goriounova NA, Moretti M, Smoluch MT, Irth H, Clementi F, Schoffelmeer ANM, Mansvelder HD, Smit AB, Gotti C, et al. 2012. Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex. FASEB Jdoi: 10. 1096/fj. 11-198994.
27. Currie C, Gabhainn SN, Godeau E, Roberts C, Smith R, Currie D, Pickett W, Richter M, Morgan A, Barnekow V. 2008. Inequalities in young people's health: HBSC international report from the 2005/06 Survey. In Health policy for children and adolescents, 5th ed. (ed. Currie C). WHO Regional Office for Europe, Copenhagen.
28. Dani JA, Bertrand D. 2007. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47: 699-729.
29. Deas D. 2006. Adolescent substance abuse and psychiatric comorbidities. J Clin Psychiatry 67: 18-23.
30. DeBry SC, Tiffany ST. 2008. Tobacco-induced neurotoxicity of adolescent cognitive development (TINACD): A proposed model for the development of impulsivity in nicotine dependence. Nicotine Tob Res 10: 11-25.
31. DiFranza JR, Savageau JA, Fletcher K, O'Loughlin J, Pbert L, Ockene JK, McNeillAD, Hazelton J, Friedman K, Dussault G, et al. 2007. Symptoms of tobacco dependence after brief intermittent use: The development and assessment of nicotine dependence in youth-2 study. Arch Pediat Adol Med 161: 704-710.
32. Disney AA, Aoki C, Hawken MJ. 2007. Gain modulation by nicotine in macaque v1. Neuron 56: 701-713.
33. Doura MB, Gold AB, Keller AB, Perry DC. 2008. Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res 1215: 40-52.
34. Ellickson PL, Tucker JS, Klein DJ. 2001. High-risk behaviors associated with early smoking: Results from a 5-year follow-up. J Adolesc Health 28: 465-473.
35. Ernst M, Fudge JL. 2009. A developmental neurobiological model of motivated behavior: Anatomy, connectivity and ontogeny of the triadic nodes. Neurosci Biobehav Rev 33: 367-382.
36. Ernst M, Nelson EE, Jazbec S, McClure EB, Monk CS, Leibenluft E, Blair J, PineDS. 2005. Amygdala and nucleus accumbens in responses to receipt and omission of gains in adults and adolescents. Neuroimage 25: 1279-1291.
37. Floresco SB, Braaksma DN, Phillips AG. 1999. Thalamic-cortical-striatal circuitry subserves working memory during delayed responding on a radial arm maze. J Neurosci 19: 11061-11071.
38. Fountain SB, Rowan JD, Kelley BM, Willey AR, Nolley EP. 2008. Adolescent exposure to nicotine impairs adult serial pattern learning in rats. Exp Brain Res 187: 651-656.
39. Fu XW, Lindstrom J, Spindel ER. 2009. Nicotine activates and up-regulates nicotinic acetylcholine receptors in bronchial epithelial cells. Am J Resp Cell Mol Biol 41: 93-99.
40. Gabbott PL, Warner TA, Jays PR, Salway P, Busby SJ. 2005. Prefrontal cortex in the rat: Projections to subcortical autonomic, motor, and limbic centers. J Comp Neurol 492: 145-177.
41. Galvan A, Hare TA, Parra CE, Penn J, Voss H, Glover G, Casey BJ. 2006. Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. J Neurosci 26: 6885-6892.
42. Galvan A, Hare T, Voss H, Glover G, Casey BJ. 2007. Risk-taking and the adolescent brain: Who is at risk? Dev Sci 10: F8-F14.
43. Giedd JN. 2004. Structural magnetic resonance imaging of the adolescent brain. Ann NY Acad Sci 1021: 77-85.
44. Gil Z, Connors BW, Amitai Y. 1997. Differential regulation of neocortical synapses by neuromodulators and activity. Neuron 19: 679-686.
45. Gioanni Y, Rougeot C, Clarke PB, Lepouse C, Thierry AM, Vidal C. 1999. Nicotinic receptors in the rat prefrontal cortex: Increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. Eur J Neurosci 11: 18-30.
46. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TFIII., Herman DH, Clasen LS, Toga AW, et al. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci 101: 8174-8179.
47. Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC. 2002. Characterization of nicotinic agonist-induced [H-3] dopamine release from synaptosomes prepared from four mouse brain regions. J Pharmacol Exp Ther 301: 651-660.
48. Grunbaum JA, Kann L, Kinchen S, Ross J, Hawkins J, Lowry R, Harris WA, McManus T, Chyen D, Collins J. 2004. Youth risk behavior surveillance-United States, 2003. MMWR Surveill Summ 53: 1-96.
49. Guillem K, Bloem B, Poorthuis RB, Loos M, Smit AB, Maskos U, Spijker S, Mansvelder HD. 2011. Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention. Science 333: 888-891.
50. Gulledge AT, Park SB, Kawaguchi Y, Stuart GJ. 2007. Heterogeneity of phasic cholinergic signaling in neocortical neurons. J Neurophysiol 97: 2215-2229.
51. Gupta DS, McCullumsmith RE, Beneyto M, Haroutunian V, Davis KL, Meador-Woodruff JH. 2005. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse 57: 123-131.
52. Helton DR, Tizzano JP, Monn JA, Schoepp DD, Kallman MJ. 1997. LY354740: A metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. Neuropharmacology 36: 1511-1516.
53. Iniguez SD, Warren BL, Parise EM, Alcantara LF, Schuh B, Maffeo ML, ManojlovicZ, Bolanos-Guzman CA. 2008. Nicotine exposure during adolescence induces a depression-like state in adulthood. Neuropsychopharmacology 34: 1609-1624.
54. Jacobsen LK, Krystal JH, Mencl WE, Westerveld M, Frost SJ, Pugh KR. 2005. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 57: 56-66.
55. Jacobsen LK, Mencl WE, Constable RT, Westerveld M, Pugh KR. 2007. Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl) 193: 557-566.
56. Jay TM, Witter MP. 1991. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 313: 574-586.
57. Ji D, Dani JA. 2000. Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 83: 2682-2690.
58. Ji D, Lape R, Dani JA. 2001. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31: 131-141.
59. Johnson JG, Cohen P, Pine DS, Klein DF, Kasen S, Brook JS. 2000. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA 284: 2348-2351.
60. Jones S, Yakel JL. 1997. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J Physiol 504: 603-610.
61. Kalmijn S, van Boxtel MP, Verschuren MW, Jolles J, Launer LJ. 2002. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am J Epidem 156: 936-944.
62. Kandel DB, Chen K. 2000. Extent of smoking and nicotine dependence in the United States: 1991-1993. Nicotine Tob Res 2: 263-274.
63. Kapfer C, Glickfeld LL, Atallah BV, Scanziani M. 2007. Supralinear increase of recurrent inhibition during sparse activity in the somatosensory cortex. Nat Neurosci 10: 743-753.
64. Kassam SM, Herman PM, Goodfellow NM, Alves NC, Lambe EK. 2008. Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors. J Neurosci 28: 8756-8764.
65. Kawaguchi Y. 1993. Groupings of nonpyramidal and pyramidal cells with specific physiological and morphological characteristics in rat frontal cortex. J Neurophysiol 69: 416-431.
66. Kawaguchi Y, Kondo S. 2002. Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol 31: 277-287.
67. Kawaguchi Y, Kubota Y. 1997. GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 7: 476-486.
68. Kawai H, Lazar R, Metherate R. 2007. Nicotinic control of axon excitability regulates thalamocortical transmission. Nat Neurosci 10: 1168-1175.
69. Kenny PJ, Markou A. 2004. The ups and downs of addiction: Role of metabotropic glutamate receptors. Trends Pharmacol Sci 25: 265-272.
70. Kenny PJ, Gasparini F, Markou A. 2003. Group II metabotropic and α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J Pharmacol Exp Ther 306: 1068-1076.
71. Kota D, Robinson SE, Imad Damaj M. 2009. Enhanced nicotine reward in adulthood after exposure to nicotine during early adolescence in mice. Biochem Pharmacol 78: 873-879.
72. Lambe EK, Picciotto MR, Aghajanian GK. 2003. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28: 216-225.
73. Le Houezec J. 2003. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: A review. Int J Tuberc Lung Dis 7: 811-819.
74. Le Novere N, Corringer PJ, Changeux JP. 2002. The diversity of subunit composition in nAChRs: Evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 53: 447-456.
75. Leslie FM, Loughlin SE, Wang R, Perez L, Lotfipour S, Belluzzia JD. 2004. Adolescent development of forebrain stimulant responsiveness: Insights from animal studies. Ann NY Acad Sci 1021: 148-159.
76. Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, Banghart MR, Dougherty DA, Goate AM, Wang JC. 2009. Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J 11: 167-177.
77. Levin ED, Rezvani AH, Montoya D, Rose JE, Swartzwelder HS. 2003. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology (Berl) 169: 141-149.
78. Liechti ME, Lhuillier L, Kaupmann K, Markou A. 2007. Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J Neurosci 27: 9077-9085.
79. Mansvelder HD, Keath JR, McGehee DS. 2002. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33: 905-919.
80. Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C. 2004. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 5: 793-807.
81. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, HeinemannSF, Collins AC. 1992. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12: 2765-2784.
82. Marks MJ, McClure-Begley TD, Whiteaker P, Salminen O, Brown RW, Cooper J, Collins AC, Lindstrom JM. 2011. Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain. J Pharmacol Exp Ther 337: 187-200.
83. Mateo Z, Porter JT. 2007. Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex. Neuroscience 146: 1062-1072.
84. McClernon FJ, Fuemmeler BF, Kollins SH, Kail ME, Ashley-Koch AE. 2008. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. Nicotine Tob Res 10: 117-127.
85. McGee R, Williams S, Poulton R, Moffitt T. 2000. A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction (Abingdon, England) 95: 491-503.
86. McGehee DS. 2002. Nicotinic receptors and hippocampal synaptic plasticity... it's all in the timing. Trends Neurosci 25: 171.
87. McGehee DS, Role LW. 1995. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57: 521-546.
88. McQuiston AR, Madison DV. 1999. Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J Neurosci 19: 2887-2896.
89. Melendez RI, Gregory ML, Bardo MT, Kalivas PW. 2004. Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex. Neuropsychopharmacology 29: 1980-1987.
90. Millar NS, Gotti C. 2009. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 56: 237-246.
91. Mineur YS, Picciotto MR. 2008. Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction. Biochem Pharmacol 75: 323-333.
92. Miwa JM, Freedman R, Lester HA. 2011. Neural systems governed by nicotinic acetylcholine receptors: Emerging hypotheses. Neuron 70: 20-33.
93. Musso F, Bettermann F, Vucurevic G, Stoeter P, Konrad A, Winterer G. 2007. Smoking impacts on prefrontal attentional network function in young adult brains. Psychopharmacology (Berl) 191: 159-169.
94. Nicoll A, Kim HG, Connors BW. 1996. Laminar origins of inhibitory synaptic inputs to pyramidal neurons of the rat neocortex. J Physiol 497: 109-117.
95. O'Dell LE. 2009. A psychobiological framework of the substrates that mediate nicotine use during adolescence. Neuropharmacology 56: 263-278.
96. Orr DP, Ingersoll GM. 1995. The contribution of level of cognitive complexity and pubertal timing to behavioral risk in young adolescents. Pediatrics 95: 528-533.
97. Ozer EM, Adams SH, Gardner LR, Mailloux DE, Wibbelsman CJ, Irwin CE Jr. 2004. Provider self-efficacy and the screening of adolescents for risky health behaviors. J Adolesc Health 35: 101-107.
98. Palucha A, Pilc A. 2005. The involvement of glutamate in the pathophysiology of depression. Drug News Perspect 18: 262-268.
99. Penschuck S, Chen-Bee CH, Prakash N, Frostig RD. 2002. In vivo modulation of a cortical functional sensory representation shortly after topical cholinergic agent application. J Comp Neurol 452: 38-50.
100. Peto R, Chen ZM, Boreham J. 1999. Tobacco-The growing epidemic. Nat Med 5: 15-17.
101. Pilc A, Chaki S, Nowak G, Witkin JM. 2008. Mood disorders: Regulation by metabotropic glutamate receptors. Biochem Pharmacol 75: 997-1006.
102. Polesskaya OO, Fryxell KJ, Merchant AD, Locklear LL, Ker KF, McDonald CG, Eppolito AK, Smith LN, Wheeler TL, Smith RF. 2007. Nicotine causes age-dependent changes in gene expression in the adolescent female rat brain. Neurotoxicol Teratol 29: 126-140.
103. Poorthuis RB, Goriounova NA, Couey JJ, Mansvelder HD. 2009. Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences. Biochem Pharmacol 78: 668-676.
104. Poorthuis RB, Bloem B, Schak B, Wester J, de Kock CPJ, Mansvelder HD. 2012. Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors. Cereb Cortex doi: 10. 1093/cercor/bhr390.
105. Porter JT, Cauli B, Tsuzuki K, Lambolez B, Rossier J, Audinat E. 1999. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J Neurosci 19: 5228-5235.
106. Pozzi L, Baviera M, Sacchetti G, Calcagno E, Balducci C, Invernizzi RW, Carli M. 2011. Attention deficit induced by blockade of N-methyl D-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: Role of metabotropic glutamate receptors 2/3. Neuroscience 176: 336-348.
107. Resnick MD, Bearman PS, Blum RW, Bauman KE, Harris KM, Jones J, Tabor J, Beuhring T, Sieving RE, Shew M, et al. 1997. Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA 278: 823-832.
108. Richards M, Jarvis MJ, Thompson N, Wadsworth ME. 2003. Cigarette smoking and cognitive decline in midlife: Evidence from a prospective birth cohort study. Am J Public Health 93: 994-998.
109. Schochet TL, Kelley AE, Landry CF. 2005. Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience 135: 285-297.
110. Schochet TL, Bremer QZ, Brownfield MS, Kelley AE, Landry CF. 2008. The dendritically targeted protein Dendrin is induced by acute nicotine in cortical regions of adolescent rat brain. Eur J Neurosci 28: 1967-1979.
111. Shram MJ, Funk D, Li Z, Le AD. 2006. Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine. Psychopharmacology (Berl) 186: 201-208.
112. Sidransky MD. 2010. How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General. U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta.
113. Silberberg G, Markram H. 2007. Disynaptic inhibition between neocortical pyramidal cells mediated by Martinotti cells. Neuron 53: 735-746.
114. Slotkin TA. 2002. Nicotine and the adolescent brain: Insights from an animal model. Neurotoxicol Teratol 24: 369-384.
115. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. 2003. Mapping cortical change across the human life span. Nat Neurosci 6: 309-315.
116. Spear LP. 2000. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
117. Steinberg L. 2005. Cognitive and affective development in adolescence. Trends Cogn Sci 9: 69-74.
118. Sun QQ, Huguenard JR, Prince DA. 2006. Barrel cortex microcircuits: Thalamocortical feedforward inhibition in spiny stellate cells is mediated by a small number of fast-spiking interneurons. J Neurosci 26: 1219-1230.
119. Takahashi T, Forsythe ID, Tsujimoto T, Barnes-Davies M, Onodera K. 1996. Presynaptic calcium current modulation by a metabotropic glutamate receptor. Science (New York, NY) 274: 594-597.
120. Tercyak KP, Lerman C, Audrain J. 2002. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J Am Acad Child Adolesc Psychiatry 41: 799-805.
121. Tierney PL, Degenetais E, Thierry AM, Glowinski J, Gioanni Y. 2004. Influence of the hippocampus on interneurons of the rat prefrontal cortex. Eur J Neurosci 20: 514-524.
122. Trauth JA, Seidler FJ, Slotkin TA. 2000. An animal model of adolescent nicotine exposure: Effects on gene expression and macromolecular constituents in rat brain regions. Brain Res 867: 29-39.
123. Tu B, Gu Z, Shen JX, Lamb PW, Yakel JL. 2009. Characterization of a nicotine-sensitive neuronal population in rat entorhinal cortex. J Neurosci 29: 10436-10448.
124. Vastola BJ, Douglas LA, Varlinskaya EI, Spear LP. 2002. Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 77: 107-114.
125. Vink JM, Willemsen G, Boomsma DI. 2003. The association of current smoking behavior with the smoking behavior of parents, siblings, friends and spouses. Addiction (Abingdon, England) 98: 923-931.
126. Wonnacott S. 1990. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11: 216-219.
127. Wonnacott S, Sidhpura N, Balfour DJK. 2005. Nicotine: From molecular mechanisms to behaviour. Curr Opin Pharmacol 5: 53.
128. Xiang Z, Huguenard JR, Prince DA. 1998. Cholinergic switching within neocortical inhibitory networks. Science (New York, NY) 281: 985-988.
129. Zucker RS. 1989. Short-term synaptic plasticity. Ann Rev Neurosci 12: 13-31.
130. Zucker RS, Regehr WG. 2002. Short-term synaptic plasticity. Ann Rev Physiol 64: 355-405.